Representative before the EPO

Employment test 51 - 200 employees
Company dna hyong monegier llp
operating since 2011
Headquarter in Amsterdam and 3 offices
active in Legal Services and IP Consulting

Representative before the EPO

Employment test 11 - 50 employees
Company dna de vries and metman
operating since 1995
Headquarter in Amsterdam and 2 offices
active in Legal Services and IP Consulting

We have observed 12 EP applications Jeannette J.M. Verbart has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after April 25, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11826306

FUSION PROTEIN SAmB, CODING GENE AND APPLICATION THEREOF

IPC classification:
A61K 48/00, A61P 31/04, C07K 19/00, C12N 15/62
Applicant:
Institute of Microbiology and Epidemiology - Academy of Military Medical Sciences, PR China
Agent:
Jeannette J.M. Verbart, Hoyng Rokh Monegier LLP
Agent:
Jeannette J.M. Verbart, De Vries & Metman
Status:
PATENT GRANTED
EP11826305

POLYPEPTIDE TF1 FOR INHIBITING TYPE 2 SHIGA TOXIN ACTIVITY, ENCODING GENE FOR SAME AND USE THEREOF

IPC classification:
A61K 38/10, A61P 1/10, C07K 7/08, C12N 15/11, C12N 15/63
Agent:
Jeannette J.M. Verbart, Hoyng Rokh Monegier LLP
Status:
PATENT GRANTED
EP12724534

MELAMINE THIOSULFATE

IPC classification:
C07D 251/54, C08K 5/3492
Agent:
Jeannette J.M. Verbart, Hoyng Rokh Monegier LLP
Agent:
Wolfgang Ellmeyer, Häupl & Ellmeyer KG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12723361

AMMONIUM SALTS OF DOPO-OH

IPC classification:
C07F 9/6571, C08K 5/5398
Agent:
Jeannette J.M. Verbart, Hoyng Rokh Monegier LLP
Agent:
Wolfgang Ellmeyer, Häupl & Ellmeyer KG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12843553

APPLICATION OF ALBIZZIA CHINENSIS EXTRACT IN PREPARATION OF MEDICINE FOR TREATMENT OF GASTRIC ULCER

IPC classification:
A61K 36/48, A61K 129/00, A61P 1/04
Agent:
Jeannette J.M. Verbart, Hoyng Rokh Monegier LLP
Agent:
Jeannette J.M. Verbart, De Vries & Metman
Status:
GRANT OF PATENT INTENDED
EP12808239

NOVOLACS MODIFIED TO BE FLAME-RETARDANT

IPC classification:
C08G 8/28, C08K 5/5313, C08K 5/5377, C08K 5/5398, C08L 63/00
Agent:
Jeannette J.M. Verbart, Hoyng Rokh Monegier LLP
Agent:
Wolfgang Ellmeyer, Häupl & Ellmeyer KG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12794686

MODIFIED BINDER COMPOSITIONS

IPC classification:
B01D 39/20, B05D 3/02, C08G 8/00, C08G 12/00, C08K 5/053, C08L 61/00, C08L 61/20, C08L 61/32, D06M 15/507
Agent:
Multiple attorneys, Hoyng Rokh Monegier LLP
Status:
GRANT OF PATENT INTENDED
EP12813852

PROCESS FOR PRODUCING LIQUID FUEL FROM GAS STREAM COMPRISING CARBON DIOXIDE

IPC classification:
C07C 29/00, C10G 2/00
Agent:
Jeannette J.M. Verbart, Hoyng Rokh Monegier LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12809272

OPTIMIZED CATALYST FOR BIOMASS PYROLYSIS

IPC classification:
B01J 23/02, B01J 23/04, B01J 35/10, B01J 37/00, B01J 37/02, B01J 37/04, B01J 37/08, C10G 1/00, C10L 1/00
Applicant:
BIOeCON International Holding N.V.
Agent:
Jeannette J.M. Verbart, Hoyng Rokh Monegier LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11797515

NOVEL GLYCOSYL HYDROLASE WITH BETA-XYLOSIDASE AND BETA-GLUCOSIDASE ACTIVITIES AND USES THEREOF

IPC classification:
C12N 1/19, C12N 9/24, C12N 9/42, C12N 15/56, C12N 15/63, C12P 17/02, C12P 19/14, C12R 1/645
Agent:
Jeannette J.M. Verbart, Hoyng Rokh Monegier LLP
Agent:
Jeannette J.M. Verbart, De Vries & Metman
Status:
EXAMINATION IN PROGRESS
EP11767228

LOW FREE FORMALDEHYDE PHENOLIC RESINS FOR ABRASIVE PRODUCTS

IPC classification:
B24D 3/28, C08G 8/28, C09G 1/02
Agent:
Jeannette J.M. Verbart, Hoyng Rokh Monegier LLP
Status:
PATENT GRANTED
EP11760461

SIMULTANEOUS HYDROLYSIS AND HYDROGENATION OF CELLULOSE

IPC classification:
C07C 31/26, C08B 15/02, C08B 16/00
Applicant:
Petrobras (Petróleo Brasileiro S.A.)
Applicant:
BIOeCON International Holding N.V.
Agent:
Jeannette J.M. Verbart, Hoyng Rokh Monegier LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN

Please Sign in to use this feature